Fabric Genomics

Fabric Genomics

paid

Fabric Genomics delivers AI-driven software for whole genome, exome, and gene panel interpretation—enabling faster rare disease diagnosis, NICU testing, and hereditary risk screening at clinical scale.

About

Fabric Genomics provides enterprise-grade, AI-powered genomics software designed for clinical environments. The platform leverages explainable AI algorithms to interpret whole genome sequencing (WGS), whole exome sequencing (WES), and targeted gene panels—delivering accurate, actionable insights for a range of clinical applications including hereditary risk screening, rare disease diagnosis, rapid NICU/PICU testing, pediatric panels, and national genome projects. The Fabric Enterprise Platform is cloud-based and built for scale, capable of processing single tests or hundreds of thousands simultaneously. It achieves 98% call accuracy in prioritized top-10 variant rankings, as validated in studies with Rady Children's Hospital. Automated ACMG classification and report generation dramatically reduce the manual bottlenecks that slow clinical genomics workflows. Fabric serves children's hospitals, large hospital systems, and commercial genomics laboratories worldwide. The platform supports partner collaborations including long-read rapid WGS (rWGS) integrations—such as a joint solution with Oxford Nanopore—and newborn genome screening programs. Clinical interpretation services are also available for organizations needing expert support beyond software. Fabric Genomics was acquired by GeneDx to further expand decentralized, AI-powered genetic testing globally.

Key Features

  • AI-Driven Variant Prioritization: Uses advanced explainable AI algorithms to rank and prioritize genetic variants, achieving 98% call accuracy in prioritized top-10 results as validated with Rady Children's Hospital.
  • Automated ACMG Classification & Reporting: Automatically classifies variants according to ACMG guidelines and generates clinical reports, eliminating major manual bottlenecks in genomic workflows.
  • Multi-Modal Sequencing Support: Supports interpretation of whole genome sequencing (WGS), whole exome sequencing (WES), targeted gene panels, and long-read rapid WGS for diverse clinical use cases.
  • Cloud-Based Scalability: Cloud-native architecture scales seamlessly from a single clinical test to hundreds of thousands, making it suitable for national genome projects and large commercial labs.
  • Clinical Interpretation Services: Offers expert clinical interpretation services alongside the software platform, providing end-to-end support for genomics programs of all sizes.

Use Cases

  • Rapid whole genome sequencing interpretation for critically ill NICU and PICU patients to identify rare genetic conditions and guide urgent treatment decisions.
  • Hereditary risk screening programs at hospital systems to identify patients at elevated risk for inherited diseases before symptoms arise.
  • Rare disease diagnosis for pediatric patients using AI-prioritized variant analysis across WGS and WES data to reduce diagnostic odysseys.
  • National and regional genome projects requiring high-throughput, scalable genomic interpretation infrastructure for large population cohorts.
  • Commercial genomics laboratories automating gene panel reporting and ACMG classification to increase throughput and reduce manual review time.

Pros

  • High Diagnostic Accuracy: Validated 98% call accuracy in top-10 variant prioritization provides clinicians with high confidence in results for critical diagnoses.
  • Significant Time Savings: Automation of ACMG classification, variant ranking, and report generation dramatically reduces turnaround time for urgent cases such as NICU patients.
  • Enterprise-Grade Scalability: Cloud-based infrastructure handles both small clinical programs and massive national genome projects without compromising performance.
  • Broad Clinical Application Coverage: Covers hereditary risk, rare disease, newborn screening, pediatric panels, and NICU testing in a single platform.

Cons

  • Enterprise Pricing: Designed for hospitals, health systems, and commercial labs—pricing is not publicly listed and may be prohibitive for smaller or independent clinical practices.
  • Implementation Complexity: Requires a structured implementation assessment and onboarding process, which may extend time-to-value for new customers.
  • Specialized Use Case: Focused exclusively on clinical genomics, making it unsuitable for general bioinformatics research or non-clinical genomic analysis workflows.

Frequently Asked Questions

What types of genomic sequencing does Fabric Genomics support?

Fabric Genomics supports whole genome sequencing (WGS), whole exome sequencing (WES), targeted gene panels, and long-read rapid WGS (rWGS) for clinical applications.

Who is Fabric Genomics designed for?

The platform is designed for children's hospitals, hospital systems, and commercial genomics laboratories that need to scale and automate clinical genetic testing workflows.

How accurate is Fabric Genomics' variant prioritization?

In a study conducted with Rady Children's Hospital, Fabric achieved 98% call accuracy in prioritized top-10 variant results, a benchmark validated in real-world clinical settings.

Is Fabric Genomics cloud-based?

Yes, Fabric's Enterprise Platform is fully cloud-based, enabling scalability from single tests to hundreds of thousands and supporting integration with partner sequencing technologies.

Who acquired Fabric Genomics?

GeneDx acquired Fabric Genomics to expand decentralized, AI-powered genetic testing at a global scale, marking a new chapter in the company's growth.

Reviews

No reviews yet. Be the first to review this tool.

Alternatives

See all